The Role of CXCR3 in Neurological Diseases
Author:
Zhou Ya-Qun1, Liu Dai-Qiang1, Chen Shu-Ping1, Sun Jia1, Zhou Xue-Rong2, Xing Cui3, Ye Da-Wei2, Tian Yu-Ke1
Affiliation:
1. Anesthesiology Institute, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China 2. Cancer Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China 3. Department of Obstetrics & Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Abstract
Background:
Neurological diseases have become an obvious challenge due to insufficient
therapeutic intervention. Therefore, novel drugs for various neurological disorders are in desperate
need. Recently, compelling evidence has demonstrated that chemokine receptor CXCR3,
which is a G protein-coupled receptor in the CXC chemokine receptor family, may play a pivotal
role in the development of neurological diseases. The aim of this review is to provide evidence for
the potential of CXCR3 as a therapeutic target for neurological diseases.
</P><P>
Methods: English journal articles that focused on the invovlement of CXCR3 in neurological diseases
were searched via PubMed up to May 2017. Moreover, reference lists from identified articles
were included for overviews.
Results:
The expression level of CXCR3 in T cells was significantly elevated in several neurological
diseases, including multiple sclerosis (MS), glioma, Alzheimer’s disease (AD), chronic pain,
human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
and bipolar disorder. CXCR3 antagonists showed therapeutic effects in these neurological diseases.
Conclusion:
These studies provided hard evidence that CXCR3 plays a vital role in the pathogenesis
of MS, glioma, AD, chronic pain, HAM/TSP and bipolar disorder. CXCR3 is a crucial molecule
in neuroinflammatory and neurodegenerative diseases. It regulates the activation of infiltrating cells
and resident immune cells. However, the exact functions of CXCR3 in neurological diseases are
inconclusive. Thus, it is important to understand the topic of chemokines and the scope of their
activity in neurological diseases.
Funder
National Natural Science Foundation of P.R. China
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology,General Medicine
Reference104 articles.
1. Oliver DJ, Borasio GD, Caraceni A, de Visser M, Grisold W, Lorenzl S, Veronese S, Voltz R. Eur J Neurol, A consensus review on the development of palliative care for patients with chronic and progressive neurological disease.,, 2015, 23,26423203, 30-38, 2. Xu Y, Tian XB, An K, Yang H, Tian YK. Eur J Pain, Lumbar transplantation of immortalized enkephalin-expressing astrocytes attenuates chronic neuropathic pain.,, 2008, 12,, 525-533,10.1016/j.ejpain.2007.08.005 3. Ramesh G, MacLean AG, Philipp MT. Mediators Inflamm, Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain.,, 2013, 2013,, 480739-,10.1155/2013/480739 4. Han D, Wu C, Xiong Q, Zhou L, Tian Y. Cell Biochem Biophys, Anti-inflammatory mechanism of bone marrow mesenchymal stem cell transplantation in rat model of spinal cord injury.,, 2015, 71,, 1341-1347,10.1007/s12013-014-0354-1 5. Griffith JW, Sokol CL, Luster AD. Annu Rev Immunol, Chemokines and chemokine receptors: positioning cells for host defense and immunity.,, 2014, 32,, 659-702,10. 1146/annurev-immunol-032713-120145
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|